Sai Parenteral's Limited (NSE:SAIPARENT)
509.30
+2.65 (0.52%)
At close: Sep 23, 2026
Sai Parenteral's Company Description
Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally.
Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, oncology, and dermatology in various dosage forms, including injectables, solid orals, liquid orals, and topicals.
The company was founded in 1988 and is based in Hyderabad, India.
Sai Parenteral's Limited
| Country | India |
| Founded | 1988 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 293 |
| CEO | D. B. Prakash |
Contact Details
Address: Plot No 39, Lavanya Arc Jayabheri Enclave Hyderabad, 500032 India | |
| Phone | 91 79 9799 1301 |
| Website | saiparenterals.com |
Stock Details
| Ticker Symbol | SAIPARENT |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| D. B. Venkoji Prakash | Chief Executive Officer |
| Anil Kumar Karusala | Executive Chairman and MD |
| Anil Kumar | Chief Financial Officer |
| Shivali Aggarwal | Company Secretary and Compliance Officer |
| Vijitha Gorrepati | Whole-Time Director |
| U. V. R. K. Subbaraju | Head of Engineering (Maintenance) |
| Gurumoorthy Kamma | Head of Corporate Quality Assurance |
| Upendra Janardhan Chinthalapudi | Head of Plant Operations |
| Mark Thulborne | Managing Director of Noumed Pharmaceuticals |
| Kunal Kakumanu | Executive Director |